José Javier Fuster

Dr. José Javier Fuster

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2017 in Science
Verified
Journal Article
Closed access
PDF file
JFJosé Javier Fuster
José Javier Fuster
SMSusan MacLauchlan
Susan MacLauchlan
MZMaría A. Zuriaga
María A. Zuriaga
MPMaya N. Polackal
Maya N. Polackal
AOAllison C. Ostriker
Allison C. Ostriker
KWKenneth Walsh
Kenneth Walsh
Faulty blood cells and heart disease: Recent studies have shown that elderly people's blood cells often harbor mutations in genes encoding certain epigenetic regulators. These mutations can lead to clonal expansion of the mutant blood cells, which increases the risk of blood cancers and cardiovascular disease. Fuster et al. generated a mouse model to investigate how one of these genes, Tet2 , affects atherosclerosis development (see the Perspective by Zhu et al. ). They found that the disease progressed more rapidly in mice transplanted with Tet2 -deficient bone marrow cells. This was due to increased secretion of interleukin-1β by Tet2 -deficient macrophages in a process that depended on the action of inflammasomes. Science , this issue p. 842 ; see also p. 798

1 February 2018 in JACC
Verified
Journal Article
Closed access
SSSoichi Sano
Soichi Sano
KOKosei Oshima
Kosei Oshima
YWYing Wang
Ying Wang
SMSusan MacLauchlan
Susan MacLauchlan
YKYasufumi Katanasaka
Yasufumi Katanasaka
KWKenneth Walsh
Kenneth Walsh

27 May 2016 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JFJosé Javier Fuster
José Javier Fuster
NONoriyuki Ouchi
Noriyuki Ouchi
NGNoyan Gokce
Noyan Gokce
KWKenneth Walsh
Kenneth Walsh
Obesity is causally linked with the development of cardiovascular disorders. Accumulating evidence indicates that cardiovascular disease is the collateral damage of obesity-driven adipose tissue dysfunction that promotes a chronic inflammatory state within the organism. Adipose tissues secrete bioactive substances, referred to as adipokines, which largely function as modulators of inflammation. The microenvironment of adipose tissue will affect the adipokine secretome, having actions on remote tissues. Obesity typically leads to the upregulation of proinflammatory adipokines and the downregulation of anti-inflammatory adipokines, thereby contributing to the pathogenesis of cardiovascular diseases. In this review, we focus on the microenvironment of adipose tissue and how it influences cardiovascular disorders, including atherosclerosis and ischemic heart diseases, through the systemic actions of adipokines.

1 April 2014 in Journal of Cardiology
Verified
Journal Article
Closed access
KNKazuto Nakamura
Kazuto Nakamura
JFJosé Javier Fuster
José Javier Fuster
KWKenneth Walsh
Kenneth Walsh

1 April 2021 in JACC
Verified
Journal Article
Closed access
DPDomingo Pascual-Figal
Domingo Pascual-Figal
ABAntoni Bayes-Genis
Antoni Bayes-Genis
MDMiriam Díez-Díez
Miriam Díez-Díez
ÁHÁlvaro Hernández-Vicente
Álvaro Hernández-Vicente
DVDavid Vázquez-Andrés
David Vázquez-Andrés
JFJosé Javier Fuster
José Javier Fuster

1 October 2020 in Cell Reports
Verified
Journal Article
Open access
JFJosé Javier Fuster
José Javier Fuster
MZMaría A. Zuriaga
María A. Zuriaga
VZVirginia Zorita
Virginia Zorita
SMSusan MacLauchlan
Susan MacLauchlan
MPMaya N. Polackal
Maya N. Polackal
KWKenneth Walsh
Kenneth Walsh
Human aging is frequently accompanied by the acquisition of somatic mutations in the hematopoietic system that induce clonal hematopoiesis, leading to the development of a mutant clone of hematopoietic progenitors and leukocytes. This somatic-mutation-driven clonal hematopoiesis has been associated with an increased incidence of cardiovascular disease and type 2 diabetes, but whether this epidemiological association reflects a direct, causal contribution of mutant hematopoietic and immune cells to age-related metabolic abnormalities remains unexplored. Here, we show that inactivating mutations in the epigenetic regulator TET2, which lead to clonal hematopoiesis, aggravate age- and obesity-related insulin resistance in mice. This metabolic dysfunction is paralleled by increased expression of the pro-inflammatory cytokine IL-1β in white adipose tissue, and it is suppressed by pharmacological inhibition of NLRP3 inflammasome-mediated IL-1β production. These findings support a causal contribution of somatic TET2 mutations to insulin resistance and type 2 diabetes.